CIK 0001590750 · Large accelerated filer
Viridian Therapeutics, Inc.\DE
Sign in to watch- Ticker
- VRDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471187261
- Phone
- 617.272.4600
- Business address
- 221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
- Former names
- MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
- 424B3 Offering Prospectus
- 8-K Event Other events
- 425 Deal Prospectus/Communication re Business Combination
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4/A Deal Registration Statement - Business Combination
- S-4/A Deal Registration Statement - Business Combination
- S-4 Deal Registration Statement - Business Combination
- 8-K Event Material agreement
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Other events
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Other events
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Other events
- 425 Deal Prospectus/Communication re Business Combination
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Other events
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Shareholder rights changed · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure · Other events
Page 34 of 41 · 819 filings